Hi Luis, I would also like to have clearer ideas a
Post# of 36537
What I understood is that on July 15th the following press release was issued:
"MIRAMAR, FL, July 15, 2020 – NuGenerex Immuno-Oncology (NuGenerex IO), today announced the closing of a $50 Million equity financing facility to support the company’s strategic and development plans. NuGenerex IO is now a public company, and once the S1 registration for this $50 Million is filed, and a subsequent S1 for an equity raise is filed in collaboration with its investment bank, the company plans to immediately apply for a listing on either the Nasdaq or NY Stock exchanges. The requisite 8k on this closing will be filed accordingly"
It seems to me, source Sec, that none of the 3 s1 filed on 14 September concerns this loan. Therefore, taking literally what was stated in the aforementioned press release, we would still have to wait for the deposit of the S1 for these 50 million and then hope for the listing ..
if I'm wrong, correct me ..